| pubmed-article:17697559 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17697559 | lifeskim:mentions | umls-concept:C0023418 | lld:lifeskim |
| pubmed-article:17697559 | lifeskim:mentions | umls-concept:C0009647 | lld:lifeskim |
| pubmed-article:17697559 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:17697559 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:17697559 | lifeskim:mentions | umls-concept:C0242602 | lld:lifeskim |
| pubmed-article:17697559 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:17697559 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:17697559 | pubmed:dateCreated | 2007-8-16 | lld:pubmed |
| pubmed-article:17697559 | pubmed:abstractText | Busulfan (Bu) is commonly used as a component of conditioning regimens for hematopoietic stem cell transplantation. Erratic gastrointestinal absorption as a result of oral administration of Bu not only affects the efficacy, but also increases the risk of toxicity. This study was to analyze the efficacy and toxicity of intravenous Bu and cyclophosphamide (Cy) conditioning before allogeneic peripheral blood stem cell transplantation (allo-PBSCT) for leukemia. | lld:pubmed |
| pubmed-article:17697559 | pubmed:language | chi | lld:pubmed |
| pubmed-article:17697559 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17697559 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17697559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17697559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17697559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17697559 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17697559 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:17697559 | pubmed:issn | 1000-467X | lld:pubmed |
| pubmed-article:17697559 | pubmed:author | pubmed-author:LiJuanJ | lld:pubmed |
| pubmed-article:17697559 | pubmed:author | pubmed-author:DongZhengZ | lld:pubmed |
| pubmed-article:17697559 | pubmed:author | pubmed-author:LuoShao-KaiSK | lld:pubmed |
| pubmed-article:17697559 | pubmed:author | pubmed-author:ZouWai-YiWY | lld:pubmed |
| pubmed-article:17697559 | pubmed:author | pubmed-author:ZhangGuo-CaiG... | lld:pubmed |
| pubmed-article:17697559 | pubmed:author | pubmed-author:PengAi-HuaAH | lld:pubmed |
| pubmed-article:17697559 | pubmed:author | pubmed-author:TongXiu-ZhenX... | lld:pubmed |
| pubmed-article:17697559 | pubmed:author | pubmed-author:XuDuo-RongDR | lld:pubmed |
| pubmed-article:17697559 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17697559 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:17697559 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17697559 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17697559 | pubmed:pagination | 914-8 | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:meshHeading | pubmed-meshheading:17697559... | lld:pubmed |
| pubmed-article:17697559 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17697559 | pubmed:articleTitle | [Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia]. | lld:pubmed |
| pubmed-article:17697559 | pubmed:affiliation | Department of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, PR China. tongxz05@163.com | lld:pubmed |
| pubmed-article:17697559 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17697559 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:17697559 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
